CLINICAL_TRIALS
trial_result
· 2023-06-15
Clinical Trial Update: A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer [Phase 3]
Summary
A Phase 3 clinical trial of CS1001 in subjects with stage III non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CStone Pharmaceuticals | Conditions: Non-Small Cell Lung Cancer Stage III | Phase 3 | Status: COMPLETED